Treatment-refractory hypereosinophilic syndrome responding to fludarabine in a 12-year-old boy

Leuk Lymphoma. 2015;56(9):2711-3. doi: 10.3109/10428194.2014.1003058. Epub 2015 Feb 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Bone Marrow / pathology
  • Child
  • Combined Modality Therapy
  • Humans
  • Hypereosinophilic Syndrome / diagnosis
  • Hypereosinophilic Syndrome / drug therapy*
  • Male
  • Treatment Outcome
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use

Substances

  • Vidarabine
  • fludarabine